150728-12-4 Usage
Uses
Used in Pharmaceutical Development:
5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione is used as a building block in the development of pharmaceuticals for its potential therapeutic properties. Its unique structure and chemical reactivity allow for the creation of new drug candidates with specific target interactions.
Used in Laboratory Research:
In the field of organic chemistry, 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione serves as a research compound for studying its chemical properties, interactions, and potential applications. It is utilized in various experiments to understand its reactivity and to explore new synthetic pathways.
Used in Organic Synthesis:
5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione is employed as an intermediate in organic synthesis for the production of other organic compounds. Its versatility in undergoing various chemical reactions makes it a valuable component in the synthesis of complex organic molecules.
Used in Chemical Industry:
In the chemical industry, 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione may be used as a raw material or a catalyst in the production of various chemical products. Its unique properties can contribute to the efficiency and selectivity of chemical processes.
Used in Material Science:
5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione has potential applications in material science, where its properties can be exploited to develop new materials with specific characteristics. Its use in this field could lead to advancements in areas such as polymers, coatings, or sensors.
Check Digit Verification of cas no
The CAS Registry Mumber 150728-12-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,7,2 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 150728-12:
(8*1)+(7*5)+(6*0)+(5*7)+(4*2)+(3*8)+(2*1)+(1*2)=114
114 % 10 = 4
So 150728-12-4 is a valid CAS Registry Number.
150728-12-4Relevant academic research and scientific papers
A method for the treatment of pulmonary arterial hypertension drug preparation method
-
Paragraph 0112; 0122; 0130-0132, (2017/10/07)
The invention provides a preparation method of a therapeutic medicine for treating pulmonary arterial hypertension and particularly provides a preparation method of a key intermediate compound as shown in a formula (IV). According to the method, the compound as shown in the formula (IV) is obtained by means of reaction of a compound as shown in a formula (II) and a compound as shown in a formula (III). The preparation method is easily available in raw materials, low in cost, mild in condition and suitable for industrialized production. The formulae (IV), (II) and (III) are as shown in the specification.
PROCESS FOR PREPARATION OF ENDOTHELIAL RECEPTOR ANTAGONIST (BOSENTAN)
-
Page/Page column 6-7, (2012/06/16)
The present invention relates to processes for the preparation of an endothelial receptor antagonist. The present invention particularly relates to synthesis of 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide (bosentan).
SUBSTITUTED PYRIMIDINES
-
Page/Page column 32; 34, (2008/12/07)
Disclosed herein are substituted pyrimidine-based endothelin modulators of Formula I, processes of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
